Over the last couple years, there have been several major instances of popular generics failing to prove bioequivalent to the brand name they’re based on. Blockbuster brand-name drugs may make the ...

The government’s plans to introduce data exclusivity provisions in the country’s drug regulatory framework pose a risk to the generics market, and could likely create monopolies in the pharma sector, ...